|
市場調査レポート
商品コード
1542621
ボツリヌス毒素の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測Global Botulinum Toxin Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
||||||
カスタマイズ可能
|
|||||||
| ボツリヌス毒素の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測 |
|
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 161 Pages
納期: 即日から翌営業日
|
- 全表示
- 概要
- 図表
- 目次
ボツリヌス毒素市場の世界需要は、2023年の159億9,000万米ドルから2032年には390億2,000万米ドル近くの市場規模に達すると推定され、調査期間2024～2032年のCAGRは10.42%です。
ボツリヌス毒素（BTX）は、ボツリヌス菌によって産生される好中球毒素です。神経伝達物質であるアセチルコリンの放出を阻害する猛毒物質であり、弛緩性麻痺を引き起こす可能性があります。ボツリヌス毒素の主要用途は、神経障害性疼痛、慢性偏頭痛、過度の痛み、過活動性筋運動関連障害から患者を治すための医療です。さらに、筋肉を弛緩させることで顔のしわを減らす化粧品用途にも使用できます。
市場力学
片頭痛、筋痙縮と関連疾患の有病率の増加がボツリヌス毒素の需要を牽引しています。在院日数の短縮、回復の早さ、切開の小ささなど、低侵襲治療の需要の高まりも製品需要を押し上げています。視覚的な魅力を高めることに焦点が移っているため、美容用途でのボツリヌス毒素の需要が増加しています。しかし、ボツリヌス毒素の使用に関連する副作用と製品の高コストは、その需要を抑制する可能性があります。
調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールはボツリヌス毒素の世界市場における各セグメントを包括的に評価することもできます。ボツリヌス毒素産業の成長と動向は、この調査に全体的なアプローチを記載しています。
市場セグメンテーション
ボツリヌス毒素市場レポートのこのセクションでは、国と地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家がそれぞれの製品またはサービスの対象層を特定する上で、今後の機会を支援します。
地域別分析
このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおけるボツリヌス毒素市場の現在と将来の需要を強調する地域展望を取り上げます。さらに、本レポートでは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。
ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。
目次
第1章 序文
第2章 エグゼクティブサマリー
- 市場のハイライト
- 世界市場スナップショット
第3章 ボツリヌス毒素-産業分析
- イントロダクション：市場力学
- 市場促進要因
- 市場抑制要因
- 市場機会
- 業界動向
- ポーターのファイブフォース分析
- 市場の魅力分析
第4章 バリューチェーン分析
- バリューチェーン分析
- 原材料分析
- 原材料リスト
- 原材料メーカー一覧
- 主要原材料の価格動向
- 潜在的バイヤー一覧
- マーケティングチャネル
- 直接マーケティング
- 間接マーケティング
- マーケティングチャネル発展動向
第5章 ボツリヌス毒素の世界市場分析：製品タイプ別
- 製品タイプ別概要
- 製品タイプ別過去・予測データ分析
- タイプA（ボトックス、ディスポート、ゼオミン、その他）
- タイプB
第6章 ボツリヌス毒素の世界市場分析：用途別
- 用途別概要
- 用途別過去・予測データ分析
- 治療（慢性偏頭痛、過活動膀胱、頸部ジストニア、痙縮、その他）
- 美容（ほうれい線、眉尻、額ほうれい線、その他）
第7章 ボツリヌス毒素の世界市場分析：最終用途別
- 最終用途別概要
- 最終用途別過去・予測データ分析
- 病院
- 皮膚科クリニック
- 美容センターとメドスパ
第8章 ボツリヌス毒素の世界市場分析：地域別
- 地域別展望
- イントロダクション
- 北米の売上分析
- 概要、実績と予測
- 北米：セグメント別
- 北米：国別
- 米国
- カナダ
- メキシコ
- 欧州売上分析
- 概要、実績と予測
- 欧州：セグメント別
- 欧州：国別
- 英国
- フランス
- ドイツ
- イタリア
- ロシア
- その他の欧州
- アジア太平洋売上分析
- 概要、実績と予測
- アジア太平洋：セグメント別
- アジア太平洋：国別
- 中国
- インド
- 日本
- 韓国
- オーストラリア
- 東南アジア
- その他のアジア太平洋
- ラテンアメリカ売上分析
- 概要、実績と予測
- ラテンアメリカ：セグメント別
- ラテンアメリカ：国別
- ブラジル
- アルゼンチン
- ペルー
- チリ
- その他のラテンアメリカ
- 中東・アフリカ売上分析
- 概要、実績と予測
- 中東・アフリカ：セグメント別
- 中東・アフリカ：国別一覧
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他の中東・アフリカ
第9章 ボツリヌス毒素企業の競合情勢
- ボツリヌス毒素市場の競合
- 提携・協力・契約
- 合併・買収
- 新製品発売
- その他の開発
第10章 企業プロファイル
- 上位企業の市場シェア分析
- 市場集中度
- Ipsen Group
- Allergen Inc.
- Medy-Tox Inc.
- Merz Pharma
- US Worldmeds
- Evolus
- Galderma
- Metabiologics Inc.
- Lanzhou Institute Of Biological Products
LIST OF TABLES
- Market Snapshot
- Drivers: Impact Analysis
- Restraints: Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- Analysis By Product Type (USD MN)
- Type A (Botox, Dysport, Xeomin, Others) Market Sales By Geography (USD MN)
- Type B Market Sales By Geography (USD MN)
- Analysis By Application (USD MN)
- Therapeutic (Chronic Migraine, Overactive Bladder, Cervical Dystonia, Spasticity, Others) Market Sales By Geography (USD MN)
- Aesthetic (Glabellar Lines, Crow's Feet, Forehead Lines, Others) Market Sales By Geography (USD MN)
- Analysis By End-use (USD MN)
- Hospitals Market Sales By Geography (USD MN)
- Dermatology Clinics Market Sales By Geography (USD MN)
- Cosmetic Centers And Medspas Market Sales By Geography (USD MN)
- Global Botulinum Toxin Market Sales By Geography (USD MN)
- North America Market Analysis (USD MN)
- United States Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate By Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Botulinum Toxin Report
- Market Research Process
- Market Research Methodology
- Global Botulinum Toxin Market Size, By Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis By Product Type
- Market Attractiveness Analysis By Application
- Market Attractiveness Analysis By End-use
- Market Attractiveness Analysis By Region
- Value Chain Analysis
- Global Market Analysis By Product Type (USD MN)
- Type A (Botox, Dysport, Xeomin, Others) Market Sales By Geography (USD MN)
- Type B Market Sales By Geography (USD MN)
- Global Market Analysis By Application (USD MN)
- Therapeutic (Chronic Migraine, Overactive Bladder, Cervical Dystonia, Spasticity, Others) Market Sales By Geography (USD MN)
- Aesthetic (Glabellar Lines, Crow's Feet, Forehead Lines, Others) Market Sales By Geography (USD MN)
- Global Market Analysis By End-use (USD MN)
- Hospitals Market Sales By Geography (USD MN)
- Dermatology Clinics Market Sales By Geography (USD MN)
- Cosmetic Centers And Medspas Market Sales By Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
The global demand for Botulinum Toxin Market is presumed to reach the market size of nearly USD 39.02 Billion by 2032 from USD 15.99 Billion in 2023 with a CAGR of 10.42% under the study period 2024-2032.
Botulinum toxin (BTX) is the neutrotoxin produced by bacterium Clostridium botulinum. It is a highly poisonous substance that inhibits the release of acetylcholine, a neurotransmitter that may cause flaccid paralysis. The prominent use of botulinum toxin is in medicine to cure the patient from neuropathic pain, chronic migraine, excessive pain, and overactive muscle movement related disorders. In addition, it can be used in cosmetics applications, for reducing facial wrinkles by relaxing the muscles
MARKET DYNAMICS
Increasing prevalence of migraine, muscle spasticity & related conditions is driving the demand for the botulinum toxin. The growing demand of minimally invasive treatments for reducing hospital stays, faster recovery, and small incision is also pushing the product demand higher. The shifting focus towards enhancing visual appeal has increased the demand for botulinum toxin in cosmetic application. However, the high cost of the product with side effects associated with the usage of botulinum toxin may curb its demand.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Botulinum Toxin. The growth and trends of Botulinum Toxin industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Botulinum Toxin market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
- Type A (Botox, Dysport, Xeomin, Others)
- Type B
By Application
- Therapeutic (Chronic Migraine, Overactive Bladder, Cervical Dystonia, Spasticity, Others)
- Aesthetic (Glabellar Lines, Crow's Feet, Forehead Lines, Others)
By End-use
- Hospitals
- Dermatology Clinics
- Cosmetic Centers And Medspas
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Botulinum Toxin market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Botulinum Toxin market include Ipsen Group, Allergen Inc., Medy-Tox Inc., Merz Pharma, US Worldmeds, Evolus, Galderma, Metabiologics Inc., Lanzhou Institute Of Biological Products. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1. PREFACE
- 1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3. BOTULINUM TOXIN - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend
5. GLOBAL BOTULINUM TOXIN MARKET ANALYSIS BY PRODUCT TYPE
- 5.1. Overview By Product Type
- 5.2. Historical and Forecast Data Analysis By Product Type
- 5.3. Type A (Botox, Dysport, Xeomin, Others) Historic and Forecast Sales By Regions
- 5.4. Type B Historic and Forecast Sales By Regions
6. GLOBAL BOTULINUM TOXIN MARKET ANALYSIS BY APPLICATION
- 6.1. Overview By Application
- 6.2. Historical and Forecast Data Analysis By Application
- 6.3. Therapeutic (Chronic Migraine, Overactive Bladder, Cervical Dystonia, Spasticity, Others) Historic and Forecast Sales By Regions
- 6.4. Aesthetic (Glabellar Lines, Crow's Feet, Forehead Lines, Others) Historic and Forecast Sales By Regions
7. GLOBAL BOTULINUM TOXIN MARKET ANALYSIS BY END-USE
- 7.1. Overview By End-use
- 7.2. Historical and Forecast Data Analysis By End-use
- 7.3. Hospitals Historic and Forecast Sales By Regions
- 7.4. Dermatology Clinics Historic and Forecast Sales By Regions
- 7.5. Cosmetic Centers And Medspas Historic and Forecast Sales By Regions
8. GLOBAL BOTULINUM TOXIN MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis
9. COMPETITIVE LANDSCAPE OF THE BOTULINUM TOXIN COMPANIES
- 9.1. Botulinum Toxin Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10. COMPANY PROFILES OF BOTULINUM TOXIN INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Ipsen Group
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
- 10.4. Allergen Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
- 10.5. Medy-Tox Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
- 10.6. Merz Pharma
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
- 10.7. US Worldmeds
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
- 10.8. Evolus
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
- 10.9. Galderma
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
- 10.10. Metabiologics Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
- 10.11. Lanzhou Institute Of Biological Products
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
